Targeting Fatty Acid Synthase in Breast and Endometrial Cancer: An Alternative to Selective Estrogen Receptor Modulators?

Ruth Lupu; Javier A. Menendez

doi:10.1210/en.2006-0486

journal article Sep 01, 2006

Targeting Fatty Acid Synthase in Breast and Endometrial Cancer: An Alternative to Selective Estrogen Receptor Modulators?

Ruth Lupu Javier A. Menendez

Endocrinology Vol. 147 No. 9 pp. 4056-4066 · The Endocrine Society

View at Publisher Save 10.1210/en.2006-0486

Topics

No keywords indexed for this article. Browse by subject →

References

102

[1]

Jensen "The estrogen receptor: a model for molecular medicine" Clin Cancer Res (2003)

[2]

Jordan "Tamoxifen: a most unlikely pioneering medicine" Nat Rev Drug Discov (2003) 10.1038/nrd1031

[3]

Fisher "Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study" J Natl Cancer Inst (1998) 10.1093/jnci/90.18.1371

[4]

Dunn "Prevention of hormone-related cancers: breast cancer" J Clin Oncol (2005) 10.1200/jco.2005.08.028

[5]

Osborne "Selective estrogen receptor modulators: structure, function, and clinical use" J Clin Oncol (2000) 10.1200/jco.2000.18.17.3172

[6]

Gradishar "Advances in endocrine therapy for the treatment and prevention of breast cancer" Cancer Chemother Biol Response Modif (2003) 10.1016/s0921-4410(03)21009-7

[7]

Fornander "Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers" Lancet (1989) 10.1016/s0140-6736(89)91141-0

[8]

Endometrial Cancer in Tamoxifen-Treated Breast Cancer Patients: Findings From the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 *

Bernard Fisher, JOSEPH P. COSTANTINO, Carol K. Redmond et al.

JNCI Journal of the National Cancer Institute 1994 10.1093/jnci/86.7.527

[9]

Osipo "The consequences of exhaustive antiestrogen therapy in breast cancer: estrogen-induced tumor cell death" Exp Biol Med (Maywood) (2004) 10.1177/153537020422900804

[10]

Kurokawa "ErbB (HER) receptors can abrogate antiestrogen action in human breast cancer by multiple signaling mechanisms" Clin Cancer Res (2003)

[11]

Kurokawa "Inhibition of erbB receptor (HER) tyrosine kinases as a strategy to abrogate antiestrogen resistance in human breast cancer" Clin Cancer Res (2001)

[12]

Shou "Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer" J Natl Cancer Inst (2004) 10.1093/jnci/djh166

[13]

Osborne "Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer" Clin Cancer Res (2005) 10.1158/1078-0432.865s.11.2

[14]

Yao "Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice" Clin Cancer Res (2000)

[15]

Osipo "Paradoxical action of fulvestrant in estradiol-induced regression of tamoxifen-stimulated breast cancer" J Natl Cancer Inst (2003) 10.1093/jnci/djg079

[16]

Smith "Aromatase inhibitors in breast cancer" N Engl J Med (2003) 10.1056/nejmra023246

[17]

Simpson "Aromatase and its inhibitors: significance for breast cancer therapy" Recent Prog Horm Res (2002) 10.1210/rp.57.1.317

[18]

Santen "Use of aromatase inhibitors in breast carcinoma" Endocr Relat Cancer (1999) 10.1677/erc.0.0060075

[19]

Goss "Aromatase inhibitors in the treatment and prevention of breast cancer" J Clin Oncol (2001) 10.1200/jco.2001.19.3.881

[20]

Goss "Tamoxifen resistant and refractory breast cancer: the value of aromatase inhibitors" Drugs (2002) 10.2165/00003495-200262060-00007

[21]

Lewis "Targeting oestrogen to kill the cancer but not the patient" Br J Cancer (2004) 10.1038/sj.bjc.6601627

[22]

Wakil "Fatty acid synthase, a proficient multifunctional enzyme" Biochemistry (1989) 10.1021/bi00437a001

[23]

Weiss "Fatty-acid biosynthesis in man, a pathway of minor importance. Purification, optimal assay conditions, and organ distribution of fatty-acid synthase" Biol Chem Hoppe Seyler (1986) 10.1515/bchm3.1986.367.2.905

[24]

Clarke "Regulation of fatty acid synthase gene expression: an approach for reducing fat accumulation" J Anim Sci (1993) 10.2527/1993.7171957x

[25]

Katsurada "Effects of nutrients and hormones on transcriptional and post-transcriptional regulation of fatty acid synthase in rat liver" Eur J Biochem (1990) 10.1111/j.1432-1033.1990.tb15592.x

[26]

Kuhajda "Fatty acid synthesis: a potential selective target for antineoplastic therapy" Proc Natl Acad Sci USA (1994) 10.1073/pnas.91.14.6379

[27]

Kuhajda "Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology" Nutrition (2000) 10.1016/s0899-9007(99)00266-x

[28]

Menendez "Fatty acid synthase-catalyzed de novo fatty acid biosynthesis: from anabolic-energy-storage pathway in normal tissues to jack-of-all-trades in cancer cells" Arch Immunol Ther Exp (Warsz) (2004)

[29]

Menendez "Overexpression and hyperactivity of breast cancer-associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal α-linolenic and γ-linolenic fatty acids: a novel mechanism by which dietary fat can alter mammary tumorigenesis" Int J Oncol (2004)

[30]

Milgraum "Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma" Clin Cancer Res (1997)

[31]

Alo "Immunohistochemical expression of human erythrocyte glucose transporter and fatty acid synthase in infiltrating breast carcinomas and adjacent typical/atypical hyperplastic or normal breast tissue" Am J Clin Pathol (2001) 10.1309/5y2l-cdck-yb55-kdk6

[32]

Porter "Molecular markers in ductal carcinoma in situ of the breast" Mol Cancer Res (2003)

[33]

Swinnen "Selective activation of the fatty acid synthesis pathway in human prostate cancer" Int J Cancer (2000) 10.1002/1097-0215(20001015)88:2<176::aid-ijc5>3.0.co;2-3

[34]

Bull "Identification of potential diagnostic markers of prostate cancer and prostatic intraepithelial neoplasia using cDNA microarray" Br J Cancer (2001) 10.1054/bjoc.2001.1816

[35]

Alo "Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients" Cancer (1996) 10.1002/(sici)1097-0142(19960201)77:3<474::aid-cncr8>3.0.co;2-k

[36]

Alo "Fatty acid synthase (FAS) predictive strength in poorly differentiated early breast carcinomas" Tumori (1999) 10.1177/030089169908500108

[37]

Jensen "The prognostic value of oncogenic antigen 519 (OA-519) expression and proliferative activity detected by antibody MIB-1 in node-negative breast cancer" J Pathol (1995) 10.1002/path.1711760405

[38]

Pizer "Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells" Cancer Res (1996)

[39]

Pizer "Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer" Cancer Res (1996)

[40]

Pizer "Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts" Cancer Res (2000)

[41]

De Schrijver "RNA interference-mediated silencing of the fatty acid synthase gene attenuates growth and induces morphological changes and apoptosis of LNCaP prostate cancer cells" Cancer Res (2003)

[42]

Kusakabe "Fatty acid synthase is expressed mainly in adult hormone-sensitive cells or cells with high lipid metabolism and in proliferating fetal cells" J Histochem Cytochem (2000) 10.1177/002215540004800505

[43]

Escot "Regulation of fatty acid synthetase ribonucleic acid in the human endometrium during the menstrual cycle" J Clin Endocrinol Metab (1990) 10.1210/jcem-70-5-1319

[44]

Pizer "Expression of fatty acid synthase is closely linked to proliferation and stromal decidualization in cycling endometrium" Int J Gynecol Pathol (1997) 10.1097/00004347-199701000-00008

[45]

Chalbos "Regulation of fatty acid synthetase by progesterone in normal and tumoral human mammary glands" Rev Esp Fisiol (1990)

[46]

Chalbos "Fatty acid synthetase and its mRNA are induced by progestins in breast cancer cells" J Biol Chem (1987) 10.1016/s0021-9258(18)61050-6

[47]

Pizer "Fatty acid synthase expression in endometrial carcinoma: correlation with cell proliferation and hormone receptors" Cancer (1998) 10.1002/(sici)1097-0142(19980801)83:3<528::aid-cncr22>3.0.co;2-x

[48]

Swinnen "Coordinate regulation of lipogenic gene expression by androgens: evidence for a cascade mechanism involving sterol regulatory element binding proteins" Proc Natl Acad Sci USA (1997) 10.1073/pnas.94.24.12975

[49]

Heemers "Androgens stimulate lipogenic gene expression in prostate cancer cells by activation of the sterol regulatory element-binding protein cleavage activating protein/sterol regulatory element-binding protein pathway" Mol Endocrinol (2001) 10.1210/mend.15.10.0703

[50]

Lacasa "Progesterone stimulates adipocyte determination and differentiation 1/sterol regulatory element-binding protein 1c gene expression: potential mechanism for the lipogenic effect of progesterone in adipose tissue" J Biol Chem (2001) 10.1074/jbc.m008556200

Showing 50 of 102 references

Cited By

92

Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells

A. Vazquez‐Martin, R. Colomer · 2008

Cell Proliferation

Metrics

92

Citations

102

References

Details

Published: Sep 01, 2006
Vol/Issue: 147(9)
Pages: 4056-4066

Authors

R

Ruth Lupu

Department of Medicine (R.L.), Evanston Northwestern Healthcare Research Institute, Evanston, Illinois 60201; Department of Medicine (R.L.), Northwestern University, Feinberg School of Medicine, Chicago, Illinois 60211; Robert H. Lurie Comprehensive Cancer Center of Northwestern University (R.L.), Chicago, Illinois 60611

J

Javier A. Menendez

Fundació d’ Investigació Biomèdica de Girona Dr. Josep Trueta (J.A.M.), 17007 Girona, Catalonia, Spain; Institut Catalá d’ Oncología de Girona-Hospital Universitari de Girona Dr. Josep Trueta, Girona (J.A.M.), 170010 Catalonia, Spain

Cite This Article

Ruth Lupu, Javier A. Menendez (2006). Targeting Fatty Acid Synthase in Breast and Endometrial Cancer: An Alternative to Selective Estrogen Receptor Modulators?. Endocrinology, 147(9), 4056-4066. https://doi.org/10.1210/en.2006-0486

Targeting Fatty Acid Synthase in Breast and Endometrial Cancer: An Alternative to Selective Estrogen Receptor Modulators?

You May Also Like